| http://www.w3.org/ns/prov#value | - ?? a broad range of regulatory issues in the pharmaceutical industry, including data exclusivity, biosimilars, orphan indications, labelling, off-label issues, the promotion of medicines and industry codes of practice such as the Association of the British Pharmaceutical Industry???s Code of Practice; and
|
